It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
EW’s FA Score shows that 1 FA rating(s) are green whileIFF’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
EW’s TA Score shows that 3 TA indicator(s) are bullish while IFF’s TA Score has 5 bullish TA indicator(s).
EW (@Medical Specialties) experienced а -3.06% price change this week, while IFF (@Chemicals: Specialty) price change was -1.05% for the same time period.
The average weekly price growth across all stocks in the @Medical Specialties industry was -1.80%. For the same industry, the average monthly price growth was +3.14%, and the average quarterly price growth was +0.31%.
The average weekly price growth across all stocks in the @Chemicals: Specialty industry was +0.35%. For the same industry, the average monthly price growth was +1.73%, and the average quarterly price growth was -4.68%.
EW is expected to report earnings on Jul 24, 2025.
IFF is expected to report earnings on Aug 11, 2025.
Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.
@Chemicals: Specialty (+0.35% weekly)The specialty chemicals sector includes companies that produce chemicals and industrial gases, which are of relatively high-value, often made to customer specifications. Examples of specialty chemicals are electronic chemicals, industrial gases, coatings, adhesives and sealants, industrial and institutional cleaning chemicals. The products are often valued on the basis of their purposes/performances rather than for their composition. Linde Plc, Ecolab Inc., Air Products and Chemicals, Inc., and Dow, Inc. are some of the largest companies making specialty chemicals.
EW | IFF | EW / IFF | |
Capitalization | 57.5B | 22.1B | 260% |
EBITDA | 1.76B | -996M | -177% |
Gain YTD | 1.513 | -9.552 | -16% |
P/E Ratio | 40.98 | 1367.17 | 3% |
Revenue | 6.01B | 11.5B | 52% |
Total Cash | 1.64B | 703M | 234% |
Total Debt | 695M | 10.8B | 6% |
EW | IFF | ||
---|---|---|---|
OUTLOOK RATING 1..100 | 72 | 12 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 85 Overvalued | 53 Fair valued | |
PROFIT vs RISK RATING 1..100 | 93 | 100 | |
SMR RATING 1..100 | 20 | 91 | |
PRICE GROWTH RATING 1..100 | 54 | 59 | |
P/E GROWTH RATING 1..100 | 73 | 63 | |
SEASONALITY SCORE 1..100 | 50 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
IFF's Valuation (53) in the Household Or Personal Care industry is in the same range as EW (85) in the Medical Specialties industry. This means that IFF’s stock grew similarly to EW’s over the last 12 months.
EW's Profit vs Risk Rating (93) in the Medical Specialties industry is in the same range as IFF (100) in the Household Or Personal Care industry. This means that EW’s stock grew similarly to IFF’s over the last 12 months.
EW's SMR Rating (20) in the Medical Specialties industry is significantly better than the same rating for IFF (91) in the Household Or Personal Care industry. This means that EW’s stock grew significantly faster than IFF’s over the last 12 months.
EW's Price Growth Rating (54) in the Medical Specialties industry is in the same range as IFF (59) in the Household Or Personal Care industry. This means that EW’s stock grew similarly to IFF’s over the last 12 months.
IFF's P/E Growth Rating (63) in the Household Or Personal Care industry is in the same range as EW (73) in the Medical Specialties industry. This means that IFF’s stock grew similarly to EW’s over the last 12 months.
EW | IFF | |
---|---|---|
RSI ODDS (%) | 1 day ago70% | N/A |
Stochastic ODDS (%) | 1 day ago68% | 1 day ago58% |
Momentum ODDS (%) | 1 day ago56% | 1 day ago70% |
MACD ODDS (%) | 1 day ago57% | 1 day ago53% |
TrendWeek ODDS (%) | 1 day ago57% | 1 day ago61% |
TrendMonth ODDS (%) | 1 day ago57% | 1 day ago60% |
Advances ODDS (%) | 16 days ago62% | 5 days ago54% |
Declines ODDS (%) | 4 days ago58% | 23 days ago60% |
BollingerBands ODDS (%) | 1 day ago56% | 1 day ago65% |
Aroon ODDS (%) | 1 day ago54% | 1 day ago47% |
A.I.dvisor indicates that over the last year, IFF has been loosely correlated with DD. These tickers have moved in lockstep 60% of the time. This A.I.-generated data suggests there is some statistical probability that if IFF jumps, then DD could also see price increases.